Brief: Neurotrope Provides Corporate Update After Completing Data Analysis For Advanced Alzheimer's Disease Trial

NextTrip

22/01/2020 14:13

Jan 22 (Reuters) - Neurotrope Inc  NTRP.O :
    * NEUROTROPE PROVIDES CORPORATE UPDATE AFTER COMPLETING
BRYOSTATIN-1 DATA ANALYSIS FOR ADVANCED ALZHEIMER'S DISEASE
TRIAL
    * NEUROTROPE INC - COMPANY CONTINUES TO EXPLORE STRATEGIC
ALTERNATIVES
    * NEUROTROPE INC - NATIONAL INSTITUTE OF HEALTH AWARDS $2.7
MILLION GRANT TO NEUROTROPE
    * NEUROTROPE - ANALYSIS TO ADJUST FOR BASELINE IMBALANCE IN
IMPAIRMENT BATTERY SCORES BETWEEN TREATMENT GROUPS SHOWS
IMPROVEMENT IN COGNITIVE FUNCTION
    * NEUROTROPE INC - PLANNING TO MEET WITH FDA TO PRESENT
TOTALITY
OF CLINICAL PROGRAM DATA FOR BRYOSTATIN-1

Source text for Eikon:  ID:nPn1C2LgTa 
Further company coverage:  NTRP.O 

 ((Reuters.Briefs@thomsonreuters.com;))